| Eric Tenbrock, MD | |
|
100 High St, Buffalo, NY 14203-1126 | |
| (716) 859-2271 | |
| Not Available |
| Full Name | Eric Tenbrock |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 44 Years |
| Location | 100 High St, Buffalo, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124129820 | NPI | - | NPPES |
| 00917588 | Medicaid | NY | |
| 2807576 | Other | NY | INDEPENDENT HEALTH |
| 005008291 | Other | NY | HEALTH NOW |
| 00010178001 | Other | NY | EXCELLUS UNIVERA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 163893 (New York) | Primary |
| 207RS0012X | Internal Medicine - Sleep Medicine | 163893 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Olean General Hospital | Olean, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Memorial Medical Center | 0547259376 | 180 |
| Academic Medicine Services, Inc. | 0941105241 | 108 |
| Olean General Hospital | 9133111784 | 57 |
| Academic Medicine Services, Inc. | 0941105241 | 108 |
| Olean General Hospital | 9133111784 | 57 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Two federal laws that provide better insurance coverage for more people with mental health and substance abuse conditions are just beginning to take effect, and advocates say the changes describe the changes as a huge win for consumers that will greatly improve treatment.
The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children.
The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.
A group of researchers from Washington University in St. Louis, Agios Pharmaceuticals and ITMO University has discovered new metabolic mechanisms that regulate macrophage polarization - the unique ability of these immune cells to change their specialization depending on the required task.
› Verified 3 days ago
| Entity Name | Kaleida Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366473183 PECOS PAC ID: 7810805280 Enrollment ID: O20031105000212 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Two federal laws that provide better insurance coverage for more people with mental health and substance abuse conditions are just beginning to take effect, and advocates say the changes describe the changes as a huge win for consumers that will greatly improve treatment.
The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children.
The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.
A group of researchers from Washington University in St. Louis, Agios Pharmaceuticals and ITMO University has discovered new metabolic mechanisms that regulate macrophage polarization - the unique ability of these immune cells to change their specialization depending on the required task.
› Verified 3 days ago
| Entity Name | Olean General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649296781 PECOS PAC ID: 9133111784 Enrollment ID: O20040401001531 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Two federal laws that provide better insurance coverage for more people with mental health and substance abuse conditions are just beginning to take effect, and advocates say the changes describe the changes as a huge win for consumers that will greatly improve treatment.
The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children.
The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.
A group of researchers from Washington University in St. Louis, Agios Pharmaceuticals and ITMO University has discovered new metabolic mechanisms that regulate macrophage polarization - the unique ability of these immune cells to change their specialization depending on the required task.
› Verified 3 days ago
| Entity Name | Academic Medicine Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255394763 PECOS PAC ID: 0941105241 Enrollment ID: O20040429000839 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Two federal laws that provide better insurance coverage for more people with mental health and substance abuse conditions are just beginning to take effect, and advocates say the changes describe the changes as a huge win for consumers that will greatly improve treatment.
The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children.
The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.
A group of researchers from Washington University in St. Louis, Agios Pharmaceuticals and ITMO University has discovered new metabolic mechanisms that regulate macrophage polarization - the unique ability of these immune cells to change their specialization depending on the required task.
› Verified 3 days ago
| Entity Name | United Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902800352 PECOS PAC ID: 0547259376 Enrollment ID: O20040507000847 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Two federal laws that provide better insurance coverage for more people with mental health and substance abuse conditions are just beginning to take effect, and advocates say the changes describe the changes as a huge win for consumers that will greatly improve treatment.
The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children.
The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.
A group of researchers from Washington University in St. Louis, Agios Pharmaceuticals and ITMO University has discovered new metabolic mechanisms that regulate macrophage polarization - the unique ability of these immune cells to change their specialization depending on the required task.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Tenbrock, MD 100 High St, Buffalo, NY 14203-1126 Ph: (716) 859-2271 | Eric Tenbrock, MD 100 High St, Buffalo, NY 14203-1126 Ph: (716) 859-2271 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Two federal laws that provide better insurance coverage for more people with mental health and substance abuse conditions are just beginning to take effect, and advocates say the changes describe the changes as a huge win for consumers that will greatly improve treatment.
The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children.
The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.
A group of researchers from Washington University in St. Louis, Agios Pharmaceuticals and ITMO University has discovered new metabolic mechanisms that regulate macrophage polarization - the unique ability of these immune cells to change their specialization depending on the required task.
› Verified 3 days ago
Musa Saeed, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-1374 | |
Dr. Reena Bose, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 899 Main St, Buffalo, NY 14203 Phone: 716-878-2700 Fax: 716-878-2701 | |
Michael S Winnicki, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-4693 | |
John Crane, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-829-2676 | |
Samjot S Dhillon, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-1110 | |
Bonnie Theresa Gleason, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 565 Abbott Rd, Buffalo, NY 14220 Phone: 716-560-8416 | |
Sanjivini Wadhwa, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-4119 |